Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GLOBAL TIMES ONLINE: Weichai Power in Weifang accelerates commoditization of hydrogen fuel cell logistics vehicles
2022-09-13 09:25
Microtech to unveil implantable microsensor technology at 34th Transcatheter Cardiovascular Therapeutics (TCT) annual meeting
2022-09-13 09:11
WATERFALL SECURITY ANNOUNCES CYBERSECURITY PARTNERSHIP WITH ALSTOM
2022-09-13 09:00
CNOOC Limited Announces Kenli 6-1 Oilfield 10-1 North Block Development Project Commenced Production
2022-09-13 08:18
CStone announces China's NMPA has accepted and granted priority review to the supplemental new drug application (sNDA) for sugemalimab in the treatment of patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)
2022-09-13 08:02
Transcenta Releases Encouraging Interim Safety and Efficacy Data of the TST001 (Osemitamab) and Chemotherapy Combination Expansion Cohort for First Line Claudin18.2 Positive Gastric Cancer at ESMO Congress 2022
2022-09-13 08:00
Ground-breaking report warns chemicals industry must dramatically transform operations to avoid 4⁰C of global warming
2022-09-13 07:01
Kohler Co. Elects Current President and Chief Executive Officer David Kohler as Chair and Chief Executive Officer
2022-09-13 06:45
KAFA Partners with Minerva Project to Launch New Higher Educational Institution
2022-09-13 06:40
Financial Times: Leipzig Has One of the 20 Best Business Schools in the World
2022-09-13 06:31
Starpharma presents compelling data in Prostate Cancer at ESMO
2022-09-13 06:28
Nature's Miracle, a Leader in the Controlled Environment Agriculture Industry, Signed an MOU with Canadian Greenhouse Developer-Vermillion Growers, Inc. to Build a 60-Acre Greenhouse with Total EPC Value of US$114 Million
2022-09-13 05:00
Empire State Realty Trust Welcomes Le Café, Panera Bread, and Playa Bowls to Three New York City Properties
2022-09-13 04:30
INSTYLE MAGAZINE AUSTRALIA TO LAUNCH INAUGURAL PRINT ISSUE THIS SPRING
2022-09-13 04:00
Nomination committee of AB SKF for the Annual General Meeting 2023
2022-09-13 00:36
NCCN's New Patient Guidelines for Marginal Zone Lymphoma Help Patients and Caregivers Better Understand a Rare Form of Blood Cancer
2022-09-13 00:35
Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio
2022-09-13 00:33
SHUTTERSTOCK APPOINTS SEJAL AMIN AS CHIEF TECHNOLOGY OFFICER
2022-09-13 00:32
Woolpert Aligns Geospatial Companies and Resources to Form Woolpert Africa
2022-09-13 00:28
DarwinHealth Publication Reports Step-by-Step Protocol for its Tumor Checkpoint-Based, Compound-to-Clinic (C2C) Cancer Drug Discovery Pipeline: Elucidates a Patient-to-Model-to-Patient (PMP) Roadmap for Precision- and Mechanism-Based Identification and Clinical Validation of Novel, Investigational and FDA-Approved Therapeutic Agents Targeting Tumor Regulatory Architecture
2022-09-13 00:26
1
1544
1545
1546
1547
1548
5295